Skip to main content
TipRanks
Go Ultimate75% OFF

Recordati Industria Chimica e Farmaceutica SPA (0KBS) Share Price & Analysis

0 Followers

0KBS Stock Chart & Stats

€52.85€0.20(0.38%)
At close: 4:30 PM GMT
€52€52.5€53Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
EUR 52.85 - EUR 52.90
52-Week Range
EUR 43.78 - EUR 53.65
Previous Close
EUR 52.65
Volume
N/A
Average Volume (3M)
54.11K
Market Cap
EUR 10.91B
Enterprise Value
EUR 12.60B
Total Cash (Recent Filing)
EUR 503.26M
Total Debt (Recent Filing)
EUR 2.21B
Price to Earnings (P/E)
20.7
Beta
0.67
Next Earnings
Feb 25, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
2.54%

Bulls Say, Bears Say

Bulls Say

Strong Profitability

High gross, operating, and net margins indicate a profitable pharmaceutical model with meaningful earnings resilience. Sustained margin strength can support internal investment in medicines, commercial infrastructure, and portfolio development while providing protection against moderate revenue fluctuations.

Attractive Returns

A roughly 25% return on equity shows that Recordati is generating substantial earnings from its shareholder capital. If profitability remains durable, this level of capital efficiency can support reinvestment, strengthen shareholder returns, and reinforce the company’s financial quality.

Healthy Free Cash Flow

Free cash flow that covers about 90% of net income indicates that reported earnings are generally supported by cash generation. This improves the company’s ability to fund operations, invest in its portfolio, service obligations, and return capital without relying solely on external financing.

Bears Say

Slower Revenue Growth

The sharp slowdown in revenue growth reduces the pace at which Recordati can expand its earnings base and leverage its commercial platform. Even with resilient margins, prolonged low top-line growth could constrain operating leverage and increase reliance on portfolio execution.

Meaningful Leverage

Debt remains slightly above equity despite improving from prior years, leaving less balance-sheet flexibility than a lightly levered structure. Meaningful leverage can limit capacity for acquisitions, investment, or shareholder returns and makes financial planning more sensitive to cash-flow pressure.

Uneven Cash Conversion

Operating cash flow converting at about 46% of EBIT shows that cash realization is less consistent than the company’s accounting profitability. Historical free-cash-flow volatility can complicate funding plans and reduce confidence that strong margins will translate smoothly into deployable cash.

Recordati Industria Chimica e Farmaceutica SPA News

0KBS FAQ

What was Recordati Industria Chimica e Farmaceutica SPA’s price range in the past 12 months?
Recordati Industria Chimica e Farmaceutica SPA lowest share price was €43.78 and its highest was €53.65 in the past 12 months.
What is Recordati Industria Chimica e Farmaceutica SPA’s market cap?
Recordati Industria Chimica e Farmaceutica SPA’s market cap is €10.91B.
When is Recordati Industria Chimica e Farmaceutica SPA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Recordati Industria Chimica e Farmaceutica SPA’s earnings last quarter?
Recordati Industria Chimica e Farmaceutica SPA released its earnings results on Nov 10, 2026. The company reported €0.665 earnings per share for the quarter.
Is Recordati Industria Chimica e Farmaceutica SPA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Recordati Industria Chimica e Farmaceutica SPA pay dividends?
Recordati Industria Chimica e Farmaceutica SPA does not currently pay dividends.
What is Recordati Industria Chimica e Farmaceutica SPA’s EPS estimate?
Recordati Industria Chimica e Farmaceutica SPA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Recordati Industria Chimica e Farmaceutica SPA have?
Recordati Industria Chimica e Farmaceutica SPA has 209,125,150 shares outstanding.
What happened to Recordati Industria Chimica e Farmaceutica SPA’s price movement after its last earnings report?
Recordati Industria Chimica e Farmaceutica SPA reported an EPS of €0.665 in its last earnings report. Following the earnings report the stock price went down -0.162%.
Which hedge fund is a major shareholder of Recordati Industria Chimica e Farmaceutica SPA?
Currently, no hedge funds are holding shares in GB:0KBS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology